EXPD
26
3
DAL
50
3
AMAT
42
9
FOX
75
5
V
58
2
BAC
42
3
NWS
58
2
PNC
56
6
NTRS
50
6
TROW
43
8
KR
46
-3
JNPR
67
2
MPC
38
5
MAS
40
4
NRG
39
12
LOW
42
3
QRVO
25
17
MMC
37
-3
CAH
44
7
AEP
48
-2
EXPD
26
3
DAL
50
3
AMAT
42
9
FOX
75
5
V
58
2
BAC
42
3
NWS
58
2
PNC
56
6
NTRS
50
6
TROW
43
8
KR
46
-3
JNPR
67
2
MPC
38
5
MAS
40
4
NRG
39
12
LOW
42
3
QRVO
25
17
MMC
37
-3
CAH
44
7
AEP
48
-2
Financhill
Back

MeridianLink 10K Form

Sell
16

MLNK
MeridianLink

Last Price:
$20.34
Seasonality Move:
-4.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MLNK News And Ratings

See the #1 stock for the next 7 days that we like better than MLNK

MLNK Financial Statistics

Sales & Book Value

Annual Sales: $303.6M
Cash Flow: $18.7M
Price / Cash Flow: 23.04
Annual Sales: $5.57
Price / Book: 3.67

Profitability

EPS (TTM): -0.67000
Net Income (TTM): $-51.6M
Gross Margin: $195.1M
Return on Equity: -10.81%
Return on Assets: -5.19%

MeridianLink Earnings Forecast

Key MeridianLink Financial Ratios

  • The Gross Profit Margin over the past 18 years for MLNK is 64.27%.
  • The Selling, General & Administrative Expenses for MLNK have been equal to 42.31% of Gross Profit Margin.
  • The Research & Development expenses have been 15.65% of Revenue.
  • The Interest Expense is -89.70% of Operating Income.
  • The Net Earning history of MLNK is -14.01% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 7 years.

MeridianLink Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Software
Sector: Information Technology
Current Symbol: MLNK
Website: meridianlink.com

Debt

Debt-to-Equity Ratio: 1.12
Current Ratio: 1.86
Quick Ratio: 1.7

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 33.82

MLNK Technical Analysis vs Fundamental Analysis

Sell
16
MeridianLink (MLNK) is a Sell

Is MeridianLink a Buy or a Sell?

  • MeridianLink stock is rated a Sell
    The current MeridianLink [MLNK] share price is $20.31. The Score for MLNK is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.